Webinar link: https://buckinstitute.zoom.us/j/96142142655

A zoom link was sent to all registrants. Please check your spam and junk folders if you do not see an email in your inbox from Buck Institute. Please email communications@buckinstitute.org if you have any questions. Thank you.

Buck discovery research looking to unearth cures

Alzheimer’s is more feared than any other age-related disease. Estimates vary, but the figures are staggering: more than 5.5 million Americans, most of them age 65 or older, have dementia caused by the memory-robbing disease. The controversial FDA approval of Aduhelm (questions about efficacy and the drug’s high cost will keep it in the news for years) highlight both the desperation for treatments and the fact that  hundreds of failed clinical trials leave Alzheimer’s  a disease still without a cure. The estimated healthcare costs for treating those with Alzheimer’s was $305 billion last year. The personal burden for patients and families is incalculable.

Clearly we need new ways of approaching this disease.

Join us for an online conversation with three Buck Institute professors who are bringing insights from research on aging (aging is the largest risk factor for Alzheimer’s) to their efforts to understand the molecular drivers of Alzheimer’s and identify targets and strategies for developing treatments and preventive measures.